In January 2012 the Aker BioMarine Science Advisory Board (SAB) met with Aker BioMarine’s (AKBM) research and development scientists; the second meeting since the board was formed last fall. This meeting had a particular focus on joint health and inflammation.
Together, the board members and Aker scientists developed the basis for a planned clinical study with Superba™ Krill oil and powder compositions to further substantiate krill’s benefits in this important area. The issues surrounding the development of the study protocol were discussed in detail to establish an optimal foundation for a successful project outcome. The study will start later this year.
Furthermore, scientific presentations were given by all the SAB members providing updates and background on issues important for research involving krill products and aspects of sustainability.
Particularly, Dr. Steve Nicol gave an update on the current status for the krill biomass in the Southern Ocean. “Krill harvesting will always be subject to scrutiny,” Steve Nicol, an expert in Antarctic sustainability said, but he further pointed out that “there is no indication that the current level of krill catch has had any impact on the performance of krill predators in the area where the krill is harvested, and the impacts of krill fishing are being monitored closely by scientists, conservationists, governments and industry alike.”
Dr. Di Marzo and Dr. Banni presented the latest updates within the endocannabinoid field, followed by Dr. Calder, who gave an update on omega-3 fatty acids and their role in inflammation. Dr .Harris gave an update on the latest findings within omega-3 index research.
Aker BioMarine’s SAB was established in 2011 to offer scientific guidance to AKBM’s scientific program and consists of the following members: Dr. Sebastiano Banni, Dr. Vincenzo Di Marzo, Dr. William Harris, Dr. Philip Calder, Dr. Tomohito Hamazaki, Mr. Willem van Nieuwenhuyzen and Dr. Steve Nicol. These scientific experts directly impact the commercial and scientific activities in Aker BioMarine.
Overall, very fruitful discussions between the ASB members and the AKBM scientists were held and important recommendations for future activities were given. The next SAB meeting will be held in September 2012.
Superba™ Krill is sustainably harvested with eco-friendly methods in the Southern Atlantic Ocean near Antarctica.
Aker BioMarine Antarctic is the only krill ingredient marketer that is primary in its supply. Aker BioMarine Antarctic’s proprietary Eco-Harvesting™ technology and on-board processing result in the unique composition of Superba™ Krill Oil and provide full traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker BioMarine Antarctic’s fisheries validating its sustainable harvesting and traceability, an exclusive distinction. As part of an established commitment to substantiating krill’s health benefits, Aker BioMarine Antarctic continues to sponsor preclinical and clinical trials with krill oil containing omega-3 phospholipids, consistently demonstrating increased tissue accumulation of omega-3 fatty acids and improved blood lipid profiles.